Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

420
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
420
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

327
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
327
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

251
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
251
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

442
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
442
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

359
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
359
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

317
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
317

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The consequences of <i>Shigella</i> medically-attended diarrhoea and other leading pathogens among young children living in high-burden settings: a multi-country prospective cohort study.

EClinicalMedicine·2026
Same author

Enhancing surveillance of foodborne bacteria and antimicrobial resistance using a large centralized laboratory database: Case study of Campylobacter and nontyphoidal Salmonella in Peru.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Kinetics of Enteric Pathogen Quantity During Acute Diarrhea in Children in Resource-Limited Settings.

Open forum infectious diseases·2026
Same author

Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study.

PLoS neglected tropical diseases·2026
Same author

Impact of Asymptomatic Enteroaggregative Escherichia coli Infection and Co-Pathogen Burden on Intestinal Barrier Function, Linear Growth, and Cognitive Development in Early Childhood: Insights from a Birth Cohort Study.

The American journal of tropical medicine and hygiene·2026
Same author

Prevalence of antibiotic residues in commercial poultry feed and meat from industrial and backyard poultry in Iquitos, Perú.

IJID one health·2026

関連する実験動画

Updated: Jul 3, 2025

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
07:59

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions

Published on: September 10, 2021

3.1K

ウイルス性胃腸炎

Thomas G Flynn1, Maribel Paredes Olortegui2, Margaret N Kosek1

  • 1Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA.

Lancet (London, England)
|February 10, 2024
PubMed
まとめ
この要約は機械生成です。

ノロウイルスやその他のウイルス性胃腸炎の原因はよりよく理解されており,改善された診断法により,標的型治療が促進されています. 流行している胃腸炎ウイルスの影響を減らすためのワクチンの開発が進んでいます.

さらに関連する動画

Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR
15:16

Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR

Published on: July 22, 2012

17.3K
EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay
11:09

EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay

Published on: September 11, 2016

8.8K

関連する実験動画

Last Updated: Jul 3, 2025

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
07:59

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions

Published on: September 10, 2021

3.1K
Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR
15:16

Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR

Published on: July 22, 2012

17.3K
EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay
11:09

EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay

Published on: September 11, 2016

8.8K

科学分野:

  • 胃腸内科
  • ウイルス学
  • 感染症

背景:

  • ノロウイルスは1972年に特定され,ウイルス性胃腸炎の理解が進化した.
  • 世界的に急性胃腸炎の主な原因として認められているのは,いくつかの重要なウイルスです.
  • 現在の治療は 主に液体と電解質の補充です

研究 の 目的:

  • ウイルス性胃腸炎の科学的な理解の進化をレビューする.
  • 診断の進歩と患者と集団レベルでの介入への影響を強調する.
  • ホストの感受性や臨床管理に関する課題を特定する.

主な方法:

  • ウイルス性胃腸炎に関する文献レビュー
  • 診断の改善とその臨床的影響の分析
  • 流行している胃腸炎ウイルスに対するワクチン開発の進展の検討

主要な成果:

  • 診断の改善により 病気を正確に特定し 標的を絞った介入が可能になります
  • ロタウイルスワクチンは,世界的な罹病率と死亡率を著しく低下させました.
  • 宿主因子と重症疾患の最適な管理に関する研究は継続されています.

結論:

  • 1972年以来,ウイルス性胃腸炎の科学的な理解は大きく進歩しました.
  • 診断とワクチンは胃腸炎の管理と予防に不可欠なツールです.
  • ホストの感受性と重症疾患の管理に関するさらなる研究が必要である.